Logo Made in Germany BIO 2018

Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM

Booth number: 1501-8

About us

Research at Fraunhofer ITEM is focused on human health – and this has been so for over 35 years. The emphasis is on two aspects: firstly, on protecting health from potentially harmful, in particular airborne substances, be they gases, aerosols, particles, fibers, or nanomaterials, and secondly, on investigating and developing diagnostic and therapeutic approaches in the field of inflammatory and allergic respiratory conditions, both at the preclinical and clinical levels. The lung and the airways are at the focus of research and development, but Fraunhofer ITEM is also investigating other subject areas. Examples are the development and manufacturing of biopharmaceuticals, tumor therapy, and translational biomedical engineering.

Products and services

Development and manufacturing of your active biopharmaceutical.

Preclinical testing – both pharmacology (asthma, COPD, infection, and pulmonary fibrosis) and toxicology.

Early-phase clinical trials from first-in-human to the clinical proof of concept (asthma, COPD, infection, and pulmonary fibrosis).

Development of medical devices.
P.R.I.T.<sub>®</sub> ExpoCube<sub>®</sub>

P.R.I.T.® ExpoCube®

P.R.I.T.® ExpoCube® is a system that allows cell and tissue cultures to be exposed to airborne substances, be they pharmaceuticals or chemicals in the form of gases, aerosols, or nanoparticles. Data about the condition of the exposed cells or tissue can be collected continuously.

News & Innovations

Fraunhofer launches a pioneering collaboration: the German-Australian iCAIR project 

Battling infection and resistance Researchers from the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM have teamed up with colleagues from the Hannover Medical School (MHH) and Griffith University’s Institute for Glycomics (IfG) in Gold Coast, Australia, in the iCAIR (Fraunho...| » Further reading 

Research alliance launched, aimed at establishing bacteriophages as an approved drug 

Bacteriophages join the fight against infection Bacteria worldwide keep developing new resistances to antibiotics. Alternative therapies are urgently needed to meet this challenge. To this end, Fraunhofer ITEM, Leibniz Institute DSM-German Collection of Microorganisms and Cell Cultures, Charité ...| » Further reading 

eTRANSAFE – collaborative research project aimed at improving safety in the drug development process 

The 40 million euro European project eTRANSAFE, kicked off at the end of September 2017, is aimed at speeding up the development of better and safer medicines for patients. Coordinated by the Fundació Institut Mar d'Investigacions Mèdiques and led by the pharmaceutical company Novartis, the proje...| » Further reading 


Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM
Nikolai-Fuchs-Str. 1
30625 Hanover

Phone: +49 511 53500

Annegret, Seehafer
Head of Business Development/Marketing
Phone: +49 173 2079509

Business matching
Get in contact with German companies in 3 easy steps! With one single question you can reach all relevant German Pavilion exhibitors of your selected industrial branch.

Click here if you notice an image that violates copyright or privacy rights.

Your personal organizer

Your personal organizer

Print list  |  Save as PDF
This is your personal organizer to manage your contacts to the German exhibitors.